dc.contributor.author | Øvstegård, Rebekka | |
dc.date.accessioned | 2017-10-16T21:49:29Z | |
dc.date.available | 2017-10-16T21:49:29Z | |
dc.date.created | 2017-10-07T20:35:15Z | |
dc.date.issued | 2010-12-08 | |
dc.identifier.isbn | 978-82-17-00724-1 | |
dc.identifier.uri | http://hdl.handle.net/11250/2460456 | |
dc.description.abstract | Dengue is the most rapidly spreading mosquito-borne viral disease in the world, with an estimated 50 million infections occurring annually. Dengue infections are a significant cause of morbidity and mortality and lead to adverse social and economic impacts in many developing tropical countries. Dengue is a matter of much concern in India, where dengue is now re-emerging as one of the most important public health problems. Currently no vaccine has been licensed. The PlantVaccine project aims to develop a plant based vaccine candidate for dengue fever. This report reviews the status of and need for a dengue vaccine, easy accessibility and affordability, and overall social and economic implications of such a vaccine development in India. | nb_NO |
dc.language.iso | eng | nb_NO |
dc.publisher | Bioforsk | nb_NO |
dc.relation.ispartof | Bioforsk Rapport | |
dc.relation.ispartofseries | Bioforsk rapport;5(172) 2010 | |
dc.subject | Dengue | nb_NO |
dc.title | The status and need for a safe and affordable dengue vaccine in India. Report from the PlantVaccine project | nb_NO |
dc.type | Research report | nb_NO |
dc.description.version | publishedVersion | nb_NO |
dc.subject.nsi | VDP::Samfunnsmedisin, sosialmedisin: 801 | nb_NO |
dc.subject.nsi | VDP::Community medicine, social medicine: 801 | nb_NO |
dc.source.pagenumber | 11 | nb_NO |
dc.source.volume | 5 | nb_NO |
dc.source.issue | 172 | nb_NO |
dc.identifier.cristin | 1503059 | |
dc.relation.project | Bioforsk: 1110389 | nb_NO |
cristin.ispublished | true | |
cristin.fulltext | original | |